CORD-19:35349bb1fc9290338907b7d7f104c9db3951163b / 161463-161571 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/35349bb1fc9290338907b7d7f104c9db3951163b","sourcedb":"CORD-19","sourceid":"35349bb1fc9290338907b7d7f104c9db3951163b","text":"Dapagliflozin induced a 566-fold increase in urine glucose loss (41.0 ± 12.6 mmol/d vs. 0.07 ± 0.15 mmol/d).","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1199","span":{"begin":0,"end":108},"obj":"Sentence"},{"id":"T11854","span":{"begin":0,"end":108},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T1199","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T11854","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T366","span":{"begin":45,"end":50},"obj":"Body_part"}],"attributes":[{"id":"A366","pred":"uberon_id","subj":"T366","obj":"http://purl.obolibrary.org/obo/UBERON_0001088"},{"subj":"T366","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93adec","default":true},{"id":"CORD-19-PD-UBERON","color":"#c7ec93"}]}]}}